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For more than half a century psychiatrists have nourished recurrent hopes that endocrinology might have much to contribute to the study of mental illness. It has sometimes been suggested that the causes of mental disorder are to be found in disturbances of endocrine function. For example, laborious studies of thyroid and of adrenocortical function in schizophrenics were carried out in the hope that they would throw light on the etiology of schizophrenia. It has often been hoped that hormonal treatment would cure various forms of mental illness. Thus there have been attempts to treat involutional melancholia with Estrogens, inadequate personality with androgenic hormones, depression with cortisone, and even to treat schizophrenia with adrenalectomy. All such hopes, whether of Etiological discovery or therapeutic success, have proved illusory.
One is led to wonder why these hopes were ever raised. No doubt they derived from the observation that several endocrine diseases produce frequent and sometimes spectacular psychological symptoms. We are all familiar with the anxiety of hyperthyroidism and with the now well-known psychotic manifestations of myxoedema. Moreover it has long been taught that there is an increased incidence of mental illness at puberty, in the puerperium and at the menopause, all of them epochs of endocrine change. Such observations certainly provided adequate grounds for carrying out endocrine investigations in psychiatric disorders and one can only regret that the returns for so much labour have been so small. More recent work in this field has been less ambitious. Its aim has been to study the endo-35 crine phenomena of emotional arousal or disturbance and to regard them as part of the somatic expression of emotion. It has long been known that the autonomic nervous system plays an important role in emotion. Indeed for Lange the autonomic changes were the emotion, while for James it was their perception which constituted the emotion. The endocrine system can be regarded as an analogue of the autonomic system which transmits its coded instructions by humoral rather than nervous means. The hypothalamus, the head ganglion of the autonomic system, is an important centre for the integration of emotional behaviour and it is also the centre through which neural control of the pituitary gland is exercised. Similarly, there is evidence that the limbic region of the brain is concerned not only with emotional behaviour, but also with the regulation of pituitary-adrenal activity. Since the same areas of the brain are involved in emotional expression and endocrine regulation, it comes as no surprise to learn that emotional perturbation involves changes in endocrine activity in the experimental animal and also in man. This has, of course, been demonstrated repeatedly in the course of emotionally disturbing experiences whether these have been experimentally induced or have arisen naturally. My purpose is not to consider the endocrinology of emotion in general, but to confine myself to the endocrine changes which accompany depression of mood in man. I shall be concerned only with the pituitary and with the glands under the direct control of its trophic hormones, namely the gonads, the thyroid and the adrenal.
It is logical to begin with the pituitary, but at present there is little to say about it directly apart from the obvious remark that changes induced by emotional arousal in other glands are presumably mediated by changes in secretion of trophic hormones by the pituitary. It has recently become possible to measure with some accuracy the very small concentration of corticotrophin in human 9 519 peripheral blood. The method is difficult and timeconsuming and there are no reports of the level of blood ACTH in depression. Raised levels have previously been reported in anxiety, although the methods used were not very reliable. The methods for measuring thyroid stimulating hormone in blood are also difficult, although some work is in progress in this field in emotional disorders. There are still no data on the urinary excretion of the gonadotrophins, measured by reliable techniques, in depressed patients.
We are equally ignorant about the endocrine function of the testis in the male depressive. There is no reason to suppose that the loss of sexual desire, so common in depression, is in any way due to a decrease in the level of circulating testosterone. On the other hand, suppression of ovarian function, clinically manifest as amenorrhoea, is a well-known feature of depression. It is not really common, however, and a survey of in-patients in a mental hospital a few years ago found an incidence of just over 10 % in depressed women of child-bearing age.
Studies of thyroid function in emotional disorders were prompted by the theory of the emotional or psychosomatic origin of thyrotoxicosis. They were further stimulated by the paradoxical finding that emotionally disturbing experiences inhibited thyroid activity in certain experimental animals. The thyroid uptake of radioactive iodine has been found to be in the normal range in depressed patients and no consistent change is found if the test is repeated after recovery. The radioiodine uptake is not, however, a measure of thyroid hormone secretion and there is a good deal of variation if repeated observations are carried out on the same subject. It is thus not a very sensitive test and small changes in thyroid activity would not be detected by it. The plasma concentration of protein-bound iodine (PBI), which gives an approximate estimate of circulating thyroxine, has been measured in several series of depressives and found to be within the normal range. In two studies where repeated estimations were made, it was found that a decline in PBI accompanied recovery in some cases. This suggests that depression may give rise to some increase in circulating thyroxine, and possibly in thyroid activity, but the changes are small and inconstant. Furthermore, the fraction of plasma thyroxine which is biologically active is not bound to protein and is not actually measured as PBI. We have no information about plasma levels of free thyroxine in depression.
There are three main ways of assessing adrenocortical activity. One can measure the concentra-tion of the particular hormone, usually cortisol, in the plasma. The metabolites of the hormone may be measured in the urine and finally it is now possible to estimate the secretion rate of the hormone by the adrenal cortex. There are, of course, other adrenal hormones besides cortisol, but it is the most important one and most studies have been concerned with cortisol and its metabolites exclusively.
When cortisol is measured in the blood, an increased concentration is taken to signify increased activity of the adrenal cortex. This is true under normal conditions, although in certain circumstances, when alterations in plasma proteins have occurred, an elevation in cortisol level occurs in spite of normal adrenal activity. This occurs, for example, in pregnancy. Plasma cortisol levels have been measured in depressed patients at the Michael Reese Hospital in Chicago and also at the Maudsley Hospital (Board et al. 1957 , Gibbons & McHugh 1962 . In both institutions the mean plasma level, measured at 8 or 9 a.m., in untreated patients was approximately 20 pg/100 ml. This figure is within the normal range, but the normal mean is 12-13 p.g. In both studies the more depressed patients tended to have the highest levels and in some cases these were above the normal range. In the Maudsley series estimations were repeated at weekly intervals until the patients were ready for discharge. The mean plasma level after recovery was 11 pg/100 ml. The most common finding, when the individual cases were examined, was of a fluctuating decline in plasma cortisol accompanying clinical improvement. This was seen in about 70 % of cases. Some patients, however, showed no significant changes in plasma cortisol. One man, admitted in a state of severe depression, responded rapidly to ECT only to relapse equally dramatically before finally recovering. Despite these great changes in emotional state, his plasma cortisol never rose above the normal mean.
Studies of urinary excretion of steroids usually rely on group methods, that is chemical methods which take advantage of some reaction which is common to several metabolites of cortisol. Such methods are widely used in clinical work and they have provided a great deal of information about adrenal function in health and disease. But they are rather insensitive and they sometimes give normal values in patients with undoubted adrenocortical overactivity. Two investigations in depressives in which group methods were used may be quoted. Kurland (1964) measured urinary steroids before and after treatment in 10 depressed male patients. He found high levels of 17-ketogenic steroids before treatment and he reported a Section ofPsychiatry 521 correlation of 079 between steroid excretion and the severity of depression as judged by a rating scale. After clinical improvement, the steroid excretion had fallen by 40%. A change in the same direction, in a group of patients composed largely of women, was found by Pryce (1964) . The initial levels were not so high as those reported by Kurland and the decrease after recovery was only 23%.
More reliable information is obtained if the individual metabolites of the main adrenal hormones are measured separately. This rather heroic procedure has usually been restricted to the study of endocrine disturbances. Recently, however, it has been used to study adrenocortical activity in 5 depressed women (Ferguson et al. 1964) . The urinary excretion of cortisol and its principal metabolites was high before treatment and fell by 45 % overall after improvement in mood produced by electro-convulsive therapy. Certain other steroids, however, were distinctly low before treatment and rose by as much as 150 % after improvement. These were the 1 1-deoxy, 17- oxosteroids, which are almost exclusively metabolites of adrenal androgenic hormones. These results suggest that, during depressive illnesses, the adrenals of these women produced an increased amount of cortisol, but a very much decreased amount of androgenic hormone. This is a most unusual contrast. Ordinarily, the administration of corticotrophin causes an increased excretion of the metabolites of cortisol together with a smaller increase in androgenic metabolites.
The adrenal secretion rate of cortisol is estimated by an isotope-dilution technique which depends on the administration of a trace amount of cortisol labelled with radio-carbon or tritium. Urine is collected during the following twentyfour hours and one or more of the metabolites of cortisol are isolated and purified. The specific activity of these metabolites is determined and from this the secretion rate of cortisol during the twenty-four-hour period can be calculated. The secretion rate has so far been measured in 20 depressed patients and the results are in harmony with those of the studies already referred to. The mean rate before treatment was 25 mg per 24 hours, near the upper end of the normal range of some 8 to 28 mg. For the 10 patients judged to be severely depressed the figure was 32 mg, for the 10 moderately depressed it was 19 mg. After recovery or improvement the mean value in both groups had fallen to 14 mg, which is the normal mean reported by the originators of the method. When the individual results are scrutinized, it is found that a significant decrease in secretion rate accompanies recovery in 70 % of cases. The exceptions were mostly less severely depressed patients, but they included a typical manicdepressive woman who changed from deep gloom to mild euphoria with only an insignificant decrease in secretion rate.
One may conclude that, in cases of moderate or severe depression, there is occasionally suppression of ovarian function and, perhaps more often, a slight increase in thyroid activity. In most cases the adrenal cortex secretes more cortisol, with a consequent increase in the concentration of this hormone in blood and in the excretion of its metabolic products in urine. This increase in adrenocortical activity is only a moderate one and in only a minority of cases does it exceed the rather wide normal range. It is less than the increase produced by maximal stimulation with corticotrophin and very much less than the increase seen in well-established Cushing's syndrome. Moreover, increased secretion of cortisol is not invariable, even in severe cases, and the production of adrenal androgenic hormones in women appears to be decreased.
Have these changes any significance? There is no evidence that an increased concentration of cortisol in body fluids is any advantage to the depressed patient and it may conceivably be harmful if it persists long enough. It seems to be an example of the increased adrenocortical activity that is seen in emotional disturbance generally. As Hamburg (1961) has said, this is probably an evolutionary survival, one part of a nervous and hormonal mechanism to make energy readily available to the organism as it prepared for fight or flight. Cortisol mobilizes fat from the fat stores, promotes gluconeogenesis and generally inhibits anabolic processes. The decrease in androgen secretion fits in with this view, since androgenic steroids are anabolic agents, concerned in the conservation of energy.
